CG Oncology Inc. Common s... (CGON)
NASDAQ: CGON
· Real-Time Price · USD
26.90
0.27 (1.01%)
At close: Jun 06, 2025, 3:59 PM
26.91
0.04%
After-hours: Jun 06, 2025, 04:20 PM EDT
1.01% (1D)
| Bid | 24.21 |
| Market Cap | 2.05B |
| Revenue (ttm) | 662K |
| Net Income (ttm) | -105.56M |
| EPS (ttm) | -1.5 |
| PE Ratio (ttm) | -17.93 |
| Forward PE | -15.66 |
| Analyst | Buy |
| Ask | 29.98 |
| Volume | 917,933 |
| Avg. Volume (20D) | 1,370,968 |
| Open | 27.25 |
| Previous Close | 26.63 |
| Day's Range | 26.75 - 28.00 |
| 52-Week Range | 14.80 - 40.47 |
| Beta | 0.86 |
About CGON
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CGON
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CGON stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+4.72%
CG Oncology shares are trading higher after JP Mor...
Unlock content with
Pro Subscription
1 month ago
+25.03%
CG Oncology shares are trading higher after the company announced that cretostimogene grenadenorepvec monotherapy data was presented at the American Urological Association Annual Meeting.
